EU approves AstraZeneca immunotherapy drug for lung cancer
AstraZeneca's immunotherapy drug Imfinzi has been approved in Europe for use in lung cancer patients with inoperable disease that had advanced locally but not spread widely around the body, the drugmaker said on Monday.
from Reuters: Health News https://reut.rs/2O1KK6X
http://bit.ly/2zwRqiM